DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for Miller-Dieker lissencephaly syndrome — screening already-approved drugs against its 2-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleMiller-Dieker lissencephaly syndrome maps to a 2-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for miller-dieker lissencephaly syndrome is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
Molecular view
myosin IC (MYO1C) — MYO1C is one of the genes genetically linked to this disease in Open Targets — shown as context, not as a drug target we're pursuing: no approved-drug candidate for this disease is yet corroborated in the literature we found.
Loading structure…
helix sheet aovdrag to rotate · scroll to zoom
RCSB Protein Data Bank · entry 4BYF · 2.74 Å · ligand ADP ORTHOVANADATE (AOV). Experimental structure, not a prediction.
What the evidence adds up to
Four unrelated children with Miller-Dieker syndrome were reported in 1980, bringing the total known cases to ten. The authors emphasised that lissencephaly is not specific to this syndrome and that craniofacial, neurologic, and growth abnormalities are more helpful for diagnosis. The disorder was considered autosomal recessive at that time.
By 1998, both Miller-Dieker syndrome and isolated lissencephaly sequence had been linked to deletions and mutations in LIS1 on chromosome 17p. The two were distinguished by facial features: Miller-Dieker syndrome presents with a tall, prominent forehead that may have vertical furrowing, narrowing at the temples, widely spaced eyes with upward slanting fissures, a very short nose with anteverted nares, and a long, wide, thick upper lip whose vermilion border is inverted and angled down. In a study of five children with Miller-Dieker syndrome and 25 with isolated lissencephaly sequence, z-score pattern profiles were strikingly similar between the groups for children aged 6 months to 4 years (correlation coefficient 0.812, p<0.001). The main quantitative differences were brachycephaly, a slightly wider face, and a considerably shorter nose in Miller-Dieker syndrome. The authors concluded that the principal diagnostic discriminators are qualitative — the tall, furrowed forehead and the long, broad, thickened upper lip.
A 2003 sonographic review noted that lissencephaly involves lack of sulcations in the brain due to a failure of neuronal migration early in gestation. Sonographic findings include agenesis of the corpus callosum, dilated third ventricle, and absent sulcations. Patients diagnosed with lissencephaly do not usually develop intellectually past the three- to five-month age level. No treatment or intervention for Miller-Dieker syndrome is mentioned in any of these abstracts. What remains missing is any clinical trial, any drug tested in this population, any molecular target for therapy, and any patient stratification beyond the genetic diagnosis of LIS1 deletion or mutation.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
PEDIATRICS · 1980 · 72 citations
The Miller-Dieker Syndrome
AbstractFour unrelated children with the Miller-Dieker syndrome, previously referred to as the lissencephaly syndrome, have been evaluated, bringing to ten the number of patients reported with that disorder. We wish to emphasize that lissencephaly is etiologically non-specific and represents only one feature in this malformation syndrome. Other features, such as the craniofacial, neurologic, and growth abnormalities, are more helpful in diagnosing this autosomal recessive disorder.
Journal of Medical Genetics · 1998 · 37 citations · open access
Classical lissencephaly syndromes: does the face reflect the brain?
AbstractBoth Miller-Dieker syndrome and isolated lissencephaly sequence are associated with classical lissencephaly. Both have been shown to be associated with deletions and mutations in LIS1 on 17p. Traditionally, the two disorders have been distinguished by the presence of a characteristic facial appearance in Miller-Dieker syndrome. The forehead is tall and prominent and may have vertical furrowing. There is narrowing at the temples. Eyes are widely spaced with upward slanting fissures. The nose is very short with anteverted nares. The upper lip is long, wide, and thick. The ears may have minor flattening of the helices. By contrast, these features are not seen in isolated lissencephaly sequence. We have measured five children with Miller-Dieker syndrome (MDS) and 25 children and adolescents with isolated lissencephaly sequence (ILS). Z score (standard deviation score) pattern profiles have been formulated and compared. Patients with ILS at all ages show reduced head circumference, a round head, and a wide and flat face with a broad nose and widely spaced eyes. The most unexpected finding is the similarity of pattern profiles of ILS and MDS in the age group 6 months to 4 years. Correlation coefficient is 0.812 (p<0.001). In MDS there are a few distinguishing features, including brachycephaly, a slightly wider face, and a considerably shorter nose. Given the striking similarity of these objective pattern profiles, it seems likely that the principal diagnostic discriminators are qualitative features, specifically the tall, furrowed forehead and the long, broad, thickened upper lip, which is so thick that the vermilion border of the upper lip is inverted and angled down.
Journal of diagnostic medical sonography · 2003 · 0 citations
The Sonographic Evaluation of Lissencephaly
AbstractLissencephaly is a neural disorder characterized by lack of sulcations in the brain. In lissencephaly, the normal migration of the neuron does not occur due to an insult to the fetus early in gestation. This causes a “smooth brain” appearance. Lissencephaly is associated with syndromes such as Walker-Warburg and Miller-Dieker syndromes. Sonographic findings of lissencephaly include agenesis of the corpus collosum, dilated third ventricle, and lack of sulcations. Patients diagnosed with lissencephaly do not usually de-velop intellectually past the three- to five-month age level.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
